Prezcobix Tablet, Film Coated
Product Images NDC 59676-575

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Prezcobix (NDC 59676-575). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Janssen Products, Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Prezcobix 01)

Chemical structure of darunavir ethanolate, one of the active ingredients in PREZCOBIX PED tablets for suspension. The diagram depicts the molecular arrangement including functional groups and ethanol (C2H5OH) association.*

FDA Label Image

Chemical Structure (Prezcobix 02)

Chemical structure diagram of darunavir ethanolate, one of the active ingredients in PREZCOBIX PED tablets for suspension, showing the molecular arrangement of atoms and bonds.*

FDA Label Image

Principal Display Panel (800 mg/150 mg Tablet Bottle Label)

A comparative bar chart showing geometric mean ratios (GMR) with 90% confidence intervals for Darunavir/cobicistat once daily during the second and third trimesters of pregnancy. The chart presents pharmacokinetic parameters including total and unbound AUC and Cmin values with corresponding numerical GMR data for these periods.*

FDA Label Image

Prezcobix 03a

A graph showing the geometric mean ratio (GMR) with 90% confidence intervals for cobicistat once daily during the second and third trimesters of pregnancy. It presents AUC Total and Cmin Total compared to a baseline, indicating decreased values less than 1.0 in these periods.*

FDA Label Image

Prezcobix 04

Label for PREZCOBIX PED tablets containing 800 mg darunavir ethanolate and 150 mg cobicistat, oral tablet for suspension. It shows the proprietary name PREZCOBIX, the active ingredients darunavir and cobicistat, dosage strength 800 mg/150 mg, and a quantity of 30 tablets. The label includes manufacturer information for Janssen Products, LP, along with storage instructions and warnings.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.